CME GROUP INC. (CME) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $1.76B (period ending 2007-12-31) to $6.52B (period ending 2025-12-31) — a 7.6% annual pace across 18 year(s) of filed history.
- Net margin expanded from 37.5% to 62.5% over that same span.
- Across 54 tracked quarters, the strongest was $1.88B (quarter ending 2026-03-31) and the weakest was $647.1M (quarter ending 2009-03-31).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $6.52B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Operating income | $4.23B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Net income | $4.07B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Diluted EPS | $11.16 | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Total assets | $198.42B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Total liabilities | $169.70B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Cash & equivalents | $4.42B | 2025-12-31 | 10-K | 0001156375-26-000009 |
| Operating cash flow | $4.28B | 2025-12-31 | 10-K | 0001156375-26-000009 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $1.71B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Operating income | $1.11B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Net income | $1.04B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Diluted EPS | $2.88 | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Total assets | $194.68B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Total liabilities | $168.16B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Cash & equivalents | $2.14B | 2026-06-30 | 10-Q | 0001156375-26-000047 |
| Operating cash flow | $1.26B | 2026-03-31 | 10-Q | 0001156375-26-000020 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
CME Group Inc.’s business scale is substantial, with total assets amounting to nearly $198 billion as of the latest annual filing. The company’s revenue has grown steadily over an 18-year period, increasing from $1.76 billion in 2007 to $6.52 billion in 2025, reflecting a compound annual growth rate of 7.6%. This growth is complemented by an expanding net margin, which has risen from 37.5% to 62.5% during the same timeframe.
The mix of CME Group’s business is primarily driven by its core clearing and trading operations in financial and commodity markets. The company’s strong performance is evident in its consistent operating income, which reached $4.23 billion in 2025, and net income, standing at $4.07 billion for the same period. Diluted EPS has also grown, reaching $11.16 in 2025.
In examining the multi-year trajectory, one observes a pattern of steady growth and margin expansion, indicating robust operational efficiency. The most recent quarterly figures reveal continued strength, with revenue and net income surpassing previous quarters’ levels. In the next filing, readers should monitor CME Group’s ability to sustain this growth trajectory amidst evolving market conditions and regulatory landscapes.
Source: SEC EDGAR company facts for CIK 0001156375 · filings index